Available IPD datapackage for study 'A Phase III, Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).'

The purpose of this study is to assess the safety and effectiveness of SPD465 compared to
placebo (a capsule with no medication in it) in the treatment of ADHD. The study will also
look at how SPD465 affects the participants sleep and how they perceive their quality of
life.

本研究旨在评估SPD465对比安慰剂（不含药物的胶囊）治疗注意缺陷多动障碍（Attention Deficit Hyperactivity Disorder，ADHD）的安全性与有效性。本研究同时将考察SPD465对参与者睡眠状况的影响，以及参与者对自身生活质量的主观感知情况。